However, while SFPQ expression was significantly increased in metastatic melanoma, compared with primary tumours (Fig. 6a), analysis of TCGA-melanoma datasets showed that differential expression of SFPQ in metastatic disease was not associated with patient survival (Fig. 6b). The gene discussed is SFPQ; the disease is metastatic neoplasm.